News & Updates
Showing Psychiatry articles
Showing
Show Multimedia Only

Zuranolone improves symptoms in adults with major depressive disorder
21 Sep 2023
Treatment with zuranolone 50 mg/day in adults with major depressive disorder (MDD) results in greater improvements in depressive symptoms at day 15, demonstrating a rapid time to effect (day 3), and is generally well tolerated, with no new safety concerns compared with lower dosages, reports a study.
21 Sep 2023

Zuranolone safe, effective for postpartum depression
20 Sep 2023
Use of zuranolone significantly improves depressive symptoms, with no serious side effects, in women with severe postpartum depression (PPD), a common perinatal complication with adverse maternal and infant outcomes, results of a phase III trial have shown.
20 Sep 2023







